---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-011792"
form_type: "8-K"
ticker: null
cik: "0001061027"
company_name: "Viracta Therapeutics, Inc."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:31:37.521465+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Viracta Therapeutics to be delisted from Nasdaq effective Feb 4, 2025; expects OTC Pink listing under VIRX

## Summary
- Received Nasdaq delisting notice on Jan 31, 2025; trading suspended at open on Feb 4, 2025.
- Failed minimum bid price ($1.00) and stockholders' equity ($2.5M) continued listing requirements.
- Expects common stock to trade on OTC Pink Open Market under symbol VIRX; warns of reduced liquidity.
- No assurance of continued trading or sufficient volume on OTC Pink market.

## SEC filing metadata
- accession: 0000950170-25-011792
- form_type: 8-K
- cik: 0001061027
- company_name: Viracta Therapeutics, Inc.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061027/000095017025011792/0000950170-25-011792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061027/000095017025011792/virx-20250131.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-011792
- JSON: https://secwatch.observer/filing/0000950170-25-011792.json
- Plain text: https://secwatch.observer/filing/0000950170-25-011792.txt

## Source-grounded claims
- claim_id: 6b4bae7f6a97547bbcd38123db6b38a35169ac12
  claim: Viracta Therapeutics, Inc. received a nasdaq delisting notice notice regarding other (rules 5450(a)(1), 5550(b)(1)).
  evidence_excerpt: January 31, 2025, the Company received written notification (the “Delisting Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company’s common stock will be delisted from Nasdaq and trading in the Company’s s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1061027/000095017025011792/0000950170-25-011792-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.